A Study of RO6807952 in Patients With Diabetes Mellitus Type 2

NCT01358929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Placebo
DRUG: RO6807952

Sponsor

Hoffmann-La Roche